Skip to main content

Table 3 Prevalence of genetic determinants associated with VRSA

From: Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates

Subject Sub group No. studies No. strains Proportion (95% CI) %Weight P I2 P sig
vanA VRSA 34 181 0.71 (0.48, 0.89) 100 0 0.8515 0
vanB VRSA 16 20 0.26 (0.05, 0.52) 100 0 0.6002 0
vanC1 VRSA 4 1 0.04 (0, 0.55) 100 0.21 0.3341 0.63
SCCmec II VRSA 4 13 0.57 (0.33, 0.8) 100 0.58 0 0
SCCmec III VRSA 2 3 0.17 (0.01, 0.43) 100 0.02
SCCmec IV VRSA 6 14 0.39 (0.14, 0.67) 100 0.1 0.4635 0
  1. I2: the percentage of variance in a meta-analysis that shows study heterogeneity. VRSA: Vancomycin-resistant Staphylococcus aureus. MRSA: Methicillin-resistant Staphylococcus aureus